DFT insights into heteroatom-doped C60 nanocages as potential drug carriers for lorazepam

Abstract

Efficient delivery of lorazepam remains challenging due to its poor aqueous solubility, limited bioavailability, and delayed onset of action. In this work, a density functional theory (DFT) study was conducted to investigate the adsorption behavior of lorazepam on pristine C60, SiC59, and GeC59 nanostructures as potential drug delivery systems. Various adsorption configurations were optimized to identify the most stable binding modes and interaction mechanisms. The calculated adsorption energies indicate that C60 exhibits relatively weaker interactions compared to doped systems, while silicon and germanium doping significantly enhance the adsorption strength. In particular, the SiC59 system shows the highest stability, with adsorption energies reaching approximately −6.1 eV, indicating strong binding suitable for drug loading applications. GeC59 also demonstrates enhanced adsorption compared to C60, although weaker than Si doping. Several analytical tools were employed, including reduced density gradient (RDG–NCI) analysis, partial density of states (PDOS), natural bond orbital (NBO) analysis, infrared (IR) spectroscopy, work function (φ), and HOMO–LUMO gap, which confirm significant electronic interaction and charge transfer between the drug and nanocarrier. Solvent effects further reveal that adsorption remains energetically favorable in aqueous environments. Importantly, protonation studies under acidic conditions demonstrate a significant weakening of the interaction, confirming the feasibility of a pH-responsive drug release mechanism. Overall, these findings highlight doped C60 nanocages, especially SiC59, as promising candidates for efficient and controlled lorazepam delivery.

Graphical abstract: DFT insights into heteroatom-doped C60 nanocages as potential drug carriers for lorazepam

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
02 Feb 2026
Accepted
04 May 2026
First published
27 May 2026
This article is Open Access
Creative Commons BY-NC license

Mater. Adv., 2026, Advance Article

DFT insights into heteroatom-doped C60 nanocages as potential drug carriers for lorazepam

M. M. Seliem, M. M. Aboelnga, E. El-Bayoumy and M. El-Tahawy, Mater. Adv., 2026, Advance Article , DOI: 10.1039/D6MA00154H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements